Bayer AG PK share price logo

Bayer AG PK Share Price

NASDAQ: BAYRY

Large Cap

as on

Bayer AG PK Stock Performance

as on January 1, 1970 at 11:00 am IST

  • $11.97
    $12.12

Bayer AG PK share price movements today

Previous Close
-
Open
$12.08
Volume
965.9K
Day's Low - High
$11.97 - $12.12

Bayer AG PK Historical Returns

1 Month Return
+ 2.52 %
3 Month Return
-8.88 %
1 Year Return
+ 96.01 %
3 Year Return
-29.93 %
5 Year Return
0 %

Bayer AG PK Stock Fundamentals & Key Indicators

Check Bayer AG PK market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$47.3B

EPS (TTM)

1.1642

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

4.6081

Return On Equity TTM

-12.37%

Bayer AG PK vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bayer AG PK with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$47.3BNANA-7.94%
BUY$809.1B377.67%39.3231.67%
BUY$565.2B44.56%21.2621.83%
BUY$368.6B93.67%87.576.91%
BUY$285.5B49.04%15.8428.08%

Stock Returns calculator for Bayer AG PK Stock including INR - Dollar returns

The Bayer AG PK stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Bayer AG PK investment value today

Current value as on today

Returns

(0%)

Returns from Bayer AG PK Stock

(0%)

Dollar Impact

(0%)

Bayer AG PK Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
11,040
12,940
14,961
11,991
11,068
12,271
14,856
10,739
9,660
11,438
Gross Profit
5,903
8,046
9,023
6,617
5,416
6,283
8,773
6,375
5,353
6,937
Operating Income
-3,492
2,934
3,248
930
-3,822
3,532
2,324
13
-543
4,345
EBITDA
-2,478
3,338
4,366
1,762
1,056
1,671
-
-
-
-
Interest Expense
805
752
648
682
642
385
473
390
762
425
Depreciation
4,930
457
1,113
1,142
4,761
1,767
1,174
272
1,005
334
Income Before Tax
-4,297
1,686
2,605
-97
-4,347
-481
1,830
-426
-1,161
-3,372
Income Tax Expense
280
302
589
-71
-153
-153
-
-
-
-
Net Income
-4,877
1,458
2,173
-36
-4,644
-350
1,404
-199
-963
-3,757
Net Profit Margin
-44.18%
11.27%
14.53%
-0.31%
-41.96%
-2.86%
9.46%
-1.85%
-9.97%
-32.85%

Bayer AG PK Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
49,298
41,427
45,030
48,388
50,355
49,831
53,694
51,966
48,760
45,575
Gross Profit
27,906
27,961
25,680
28,978
27,077
30,821
32,666
30,422
26,507
26,778
Operating Income
7,042
5,903
3,914
5,041
-2,939
6,975
6,264
-150
3,327
6,139
EBITDA
7,820
7,759
6,258
8,766
-11,480
6,968
10,443
4,209
8,807
-
Interest Expense
978
871
1,615
1,848
1,596
1,347
1,857
2,047
2,358
2,265
Depreciation
-
2,660
6,352
5,365
13,259
3,056
6,503
10,020
8,783
2,785
Income Before Tax
5,887
4,577
2,318
2,880
-17,250
2,046
4,670
-1,621
-2,334
-3,129
Income Tax Expense
1,329
1,329
607
450
-1,689
1,024
504
1,321
212
-
Net Income
4,776
8,679
1,928
2,700
-18,927
1,130
4,391
-3,208
-2,669
-3,620
Net Profit Margin
9.69%
20.95%
4.28%
5.58%
-37.59%
2.27%
8.18%
-6.17%
-5.48%
-7.94%

Bayer AG PK Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
1,337
2,000
-34
-4,194
-328
1,299
-199
-963
-3,757
Operating Cash Flow
5,257
-2,180
2,410
2,111
4,997
-1,015
1,058
1,685
4,202
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-2,453
867
-692
-5,054
-2,109
-
-
-
-
Change in Cash
-908
-1,182
-837
731
1,572
-2,095
730
1,348
793

Bayer AG PK Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
3,248
1,711
2,430
-15,561
1,022
4,166
-2,941
-2,546
-3,620
Operating Cash Flow
8,134
7,917
8,207
4,903
5,089
7,093
5,117
7,368
5,930
Investing Cash Flow
-432
-34,152
-671
-4,073
855
-2,381
-
-
-
Financing Cash Flow
-1,881
23,432
-8,389
423
-5,645
-4,220
-679
-7,178
-
Change in Cash
5,682
-3,383
-867
1,006
373
607
736
284
776

Insights on Bayer AG PK

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Bayer Ag-sponsored Adr has shown positive revenue growth over the last two quarters. The revenue increased from $9.66 billion to $11.43 billion, reflecting an average increase of 15.5% per quarter.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BAYRY has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, BAYRY stock has moved up by 50.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly And Company has given 41.6% return, outperforming this stock by 71.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Bayer AG's sponsored ADR has experienced a significant decline in net profit over the last four quarters. Net profit dropped from $1.29 billion to -$3.75 billion. This represents an average decrease of 263.1% each quarter, indicating a troubling trend in its financial performance.

About Bayer AG PK

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
OrganisationBayer AG PK
HeadquartersKaiser-Wilhelm-Allee 1, Leverkusen, Germany, 51368
IndustryDrug Manufacturers - General
CEOMr. William N. Anderson
E-voting on sharesClick here to vote

Key Management of Bayer AG PK

Name

Title

Mr. William N. Anderson

Chairman of the Management Board & CEO

Mr. Wolfgang U. Nickl

CFO & Member of Management Board

Mr. Rodrigo Santos

Member of Management Board & President of the Crop Science Division

Mr. Julio Triana

Member of Management Board & President of Consumer Health Division

Mr. Bill Dodero

General Counsel and Senior VP of Law Patents & Compliance

Mr. Stefan Oelrich

Head of the Pharmaceuticals Division & Member of the Board of Management

Ms. Heike Prinz

Chief Talent Officer, Labor Director & Member of Management Board

Dr. Judith Hartmann

Member of Management Board

Mr. Alex Buschermohle

Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division

Dr. Jost Reinhard

Senior VP & Head of Investor Relations

FAQs

What is Bayer AG PK's market capitalisation today?

Bayer AG PK market capitalisation is $0.05T as on .

How to invest in Bayer AG PK Stock (BAYRY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bayer AG PK on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bayer AG PK Shares .

What is the minimum amount required to buy Bayer AG PK Stock (BAYRY) from India?

Indian investors can start investing in Bayer AG PK (BAYRY) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Bayer AG PK stock (as per the Rupee-Dollar exchange rate as on ). Learn more about fractional shares .